NCT00500344View on ClinicalTrials.gov

CAPTAIN:Choroidal Neovascularization Assessment by Pattern Electroretinography

PHASE1CompletedINTERVENTIONAL

Enrollment

17

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions

Age-related Macular Degeneration

Interventions

DRUG

Lucentis (ranibizumab)

intravitreal injection

Trial Locations (1)

63110

Washington University, St Louis

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

Washington University School of Medicine

OTHER